Indication

Sjogren's syndrome

Sjögren's syndrome is a chronic, systemic autoimmune disease primarily characterized by immune-mediated inflammation and progressive destruction of exocrine tissue, most notably the salivary and lacrimal glands. Read more about Sjogren's syndrome

99 drugs 74 manufacturers

Advertisement

Drugs that treat it

Common Sjogren's syndrome therapies.

Showing 37–45 of 99 drugs

PREDNISONE

GLUCOCORTICOSTEROIDS·PULMONARY TUBERCULOSIS·+67
Actavis Pharma

PREDNISONE

GLUCOCORTICOSTEROIDS·PULMONARY TUBERCULOSIS·+67
Hikma Pharmaceuticals USA

PREDNISONE

PULMONARY TUBERCULOSIS·+67
Lannett Company

PREDNISONE

PULMONARY TUBERCULOSIS·+67
NOVITIUM PHARMA

PREDNISOLONE

GLUCOCORTICOSTEROIDS·TRICHINOSIS·+59
PHARMACEU ASSOC

PREDNISONE

GLUCOCORTICOSTEROIDS·PULMONARY TUBERCULOSIS·+67
Mylan Pharmaceuticals
Filter & compare in the drug finder →Opens the drug finder with Sjogren's syndrome preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Sjogren's syndrome.

Sjögren's syndrome is a chronic, systemic autoimmune disease primarily characterized by immune-mediated inflammation and progressive destruction of exocrine tissue, most notably the salivary and lacrimal glands.

It predominantly affects adult women and presents with hallmark sicca symptoms, including dry eyes (keratoconjunctivitis sicca) and dry mouth (xerostomia), often accompanied by profound fatigue and arthralgias.

Pathophysiologically, lymphocytic infiltration of the glandular epithelium, aberrant B-cell activation, and autoantibody production—such as anti-Ro/SSA and anti-La/SSB—drive glandular dysfunction and can extend to cause extraglandular involvement across pulmonary, renal, neurological, and vascular systems.

Personalize your experience

Follow Sjogren's syndrome and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it